======= USP16 ======= == Gene Information == * **Official Symbol**: USP16 * **Official Name**: ubiquitin specific peptidase 16 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10600|10600]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y5T5|Q9Y5T5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=USP16&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20USP16|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604735|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |UCH| |zf-UBP| |histone H2A K63-linked deubiquitination| |monoubiquitinated histone deubiquitination| |monoubiquitinated histone H2A deubiquitination| |positive regulation of translational elongation| |monoubiquitinated protein deubiquitination| |regulation of translational elongation| |histone deubiquitination| |protein K63-linked deubiquitination| |thiol-dependent ubiquitinyl hydrolase activity| |ubiquitin binding| |cysteine-type endopeptidase activity| |protein homotetramerization| |thiol-dependent ubiquitin-specific protease activity| |positive regulation of translation| |histone binding| |mitotic nuclear division| |protein tetramerization| |positive regulation of cellular amide metabolic process| |protein deubiquitination| |transcription coactivator activity| |nuclear division| |protein modification by small protein removal| |organelle fission| |protein homooligomerization| |regulation of translation| |histone modification| |covalent chromatin modification| |regulation of cellular amide metabolic process| |cell division| |protein complex oligomerization| |posttranscriptional regulation of gene expression| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |mitotic cell cycle process| |cellular protein catabolic process| |mitotic cell cycle| |protein catabolic process| |chromatin organization| |cellular response to DNA damage stimulus| |zinc ion binding| |cellular macromolecule catabolic process| |protein modification by small protein conjugation or removal| |cell cycle process| |macromolecule catabolic process| |organonitrogen compound catabolic process| |chromosome organization| |regulation of cell cycle| |positive regulation of transcription by RNA polymerase II| |proteolysis| |cell cycle| |positive regulation of transcription, DNA-templated| |protein-containing complex assembly| |positive regulation of cellular protein metabolic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cellular response to stress| |positive regulation of protein metabolic process| |positive regulation of RNA metabolic process| |organic substance catabolic process| |cellular catabolic process| |protein-containing complex subunit organization| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp40|2-Methoxyestradiol 0.2μM R01 exp40]]|-2.06| |[[:results:exp47|Lapatinib 5μM R01 exp47]]|-1.8| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|-1.78| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|-1.77| |[[:results:exp41|BI-2536 0.001μM R01 exp41]]|-1.71| |[[:results:exp73|LJH685 5μM R02 exp73]]|-1.71| |[[:results:exp53|Suberoylanilide-Hydroxamic-Acid 0.02μM R01 exp53]]|-1.7| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|1.8| |[[:results:exp210|LB-100 2μM R05 exp210]]|1.81| |[[:results:exp513|ONC212 0.15μM R08 exp513]]|1.84| |[[:results:exp341|BRD2 inhibitor II 20μM R07 exp341]]|2.06| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|2.13| |[[:results:exp472|CI-1040 9.5μM R08 exp472]]|2.36| |[[:results:exp189|Temozolomide 200μM R04 exp189]]|2.56| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 16920 * **Expression level (log2 read counts)**: 6.43 {{:chemogenomics:nalm6 dist.png?nolink |}}